Furthermore, the existence of different forms of aberrant EGFR leads to a heterogenous expression pattern and, therefore, heterogenous signaling abilities [10], making this tumor entity even more difficult to target with specific therapeutic approaches. The gene discussed is EGFR; the disease is neoplasm.